Review article · 2021 · Open access

Pharmacogenomics in the era of next generation sequencing – from byte to bedside

Laura E. Russell, Yitian Zhou, Ahmed A. Almousa, Jasleen K. Sodhi, Chukwunonso K. Nwabufo, Volker Martin Lauschke

Drug Metabolism Reviews, 53(2), 253–278 · Published 3 April 2021 · DOI 10.1080/03602532.2021.1909613

Open PDFView at the publisherCite this paper

In brief

“Pharmacogenomics in the era of next generation sequencing – from byte to bedside” is a 2021 review article by Laura E. Russell and 5 co-authors, published in Drug Metabolism Reviews. OpenAlex counts 61 citations as of 21 November 2026, which puts it in the top 4% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Drug Metabolism Reviews.

Citations
61
Most cited in
2024 (14)
Field-weighted impact
1.15
References
211
Authors
6

Abstract

Pharmacogenetic research has resulted in the identification of a multitude of genetic variants that impact drug response or toxicity. These polymorphisms are mostly common and have been included as actionable information in the labels of numerous drugs. In addition to common variants, recent advances in Next Generation Sequencing (NGS) technologies have resulted in the identification of a plethora of rare and population-specific pharmacogenetic variations with unclear functional consequences that are not accessible by conventional forward genetics strategies. In this review, we discuss how comprehensive sequencing information can be translated into personalized pharmacogenomic advice in the age of NGS. Specifically, we provide an update of the functional impacts of rare pharmacogenetic variability and how this information can be leveraged to improve pharmacogenetic guidance. Furthermore, we critically discuss the current status of implementation of pharmacogenetic testing across drug development and layers of care. We identify major gaps and provide perspectives on how these can be minimized to optimize the utilization of NGS data for personalized clinical decision-support.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Russell, L. E., Zhou, Y., Almousa, A. A., Sodhi, J. K., Nwabufo, C. K., & Lauschke, V. M. (2021). Pharmacogenomics in the era of next generation sequencing – from byte to bedside. Drug Metabolism Reviews, 53(2), 253–278. https://doi.org/10.1080/03602532.2021.1909613

MLA 9

Russell, Laura E., et al. “Pharmacogenomics in the era of next generation sequencing – from byte to bedside.” Drug Metabolism Reviews, vol. 53, no. 2, 2021, pp. 253–278. https://doi.org/10.1080/03602532.2021.1909613.

Chicago

Russell, Laura E., Yitian Zhou, Ahmed A. Almousa, Jasleen K. Sodhi, Chukwunonso K. Nwabufo, and Volker Martin Lauschke. 2021. “Pharmacogenomics in the era of next generation sequencing – from byte to bedside.” Drug Metabolism Reviews 53 (2): 253–278. https://doi.org/10.1080/03602532.2021.1909613.

Harvard

Russell, L. E. et al. (2021) ‘Pharmacogenomics in the era of next generation sequencing – from byte to bedside’, Drug Metabolism Reviews, 53(2), pp. 253–278. doi:10.1080/03602532.2021.1909613.

IEEE

L. E. Russell, Y. Zhou, A. A. Almousa, J. K. Sodhi, C. K. Nwabufo, and V. M. Lauschke, “Pharmacogenomics in the era of next generation sequencing – from byte to bedside,” Drug Metabolism Reviews, vol. 53, no. 2, pp. 253–278, 2021, doi: 10.1080/03602532.2021.1909613.

BibTeX

@article{russell2021pharmacogenomics,
  title     = {{Pharmacogenomics in the era of next generation sequencing – from byte to bedside}},
  author    = {Russell, Laura E. and Zhou, Yitian and Almousa, Ahmed A. and Sodhi, Jasleen K. and Nwabufo, Chukwunonso K. and Lauschke, Volker Martin},
  journal   = {Drug Metabolism Reviews},
  year      = {2021},
  volume    = {53},
  number    = {2},
  pages     = {253--278},
  doi       = {10.1080/03602532.2021.1909613},
  url       = {https://doi.org/10.1080/03602532.2021.1909613}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202144
20221212
202355
20241414
20251414
20261212

Its field-weighted citation impact is 1.15: it has been cited 1.15 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • next-generation sequencing
  • rare variants
  • pharmacogenetic testing
  • personalized medicine
  • drug response
  • drug toxicity
  • clinical decision support

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Russell, L. E., Zhou, Y., Almousa, A. A., Sodhi, J. K., Nwabufo, C. K., & Lauschke, V. M. (2021). Pharmacogenomics in the era of next generation sequencing – from byte to bedside. Drug Metabolism Reviews, 53(2), 253–278. https://doi.org/10.1080/03602532.2021.1909613

How many times has this paper been cited?

61 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Drug Metabolism Reviews: sign in and open the PDF from this page.

Who wrote this paper?

Laura E. Russell, Yitian Zhou, Ahmed A. Almousa, Jasleen K. Sodhi, Chukwunonso K. Nwabufo, Volker Martin Lauschke.

What is the DOI of this paper?

10.1080/03602532.2021.1909613, permanently at https://doi.org/10.1080/03602532.2021.1909613. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.